Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Effects of Combined High Intensity Interval Training and Resistance Training [NA]
This clinical trial investigates the effects of combining high-intensity interval training with resistance training on hypertension. The stu…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Prevalence of Sub-Clinical Atrial Fibrillation in Elderly Patients With Hypertension, Detected Using an External Loop Recorder
This clinical trial update reports the prevalence of sub-clinical atrial fibrillation in elderly patients with hypertension detected using a…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Postpartum ASA and NT-proBNP [Phase 4]
Phase 4 clinical trial update evaluating the combination of postpartum aspirin (acetylsalicylic acid) and NT-proBNP with results posted.
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: The Effect of Chronic Remote Ischaemic Preconditioning on Blood Pressure in Older Adults [NA]
A clinical trial evaluating whether chronic remote ischemic preconditioning reduces blood pressure in older adults has completed.
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Moms@Home: A Storytelling-based Mobile Health Intervention to Improve Blood Pressure Management in Pregnancy [NA]
This clinical trial update describes Moms@Home, a storytelling-based mobile health intervention intended to improve blood pressure managemen…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension [Phase 3]
Phase 3 trial results comparing GMRx2 to placebo for hypertension were completed and posted on 2025-06-03, reporting on efficacy and safety …
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension [Phase 3]
Phase 3 trial results for GMRx2 in hypertension show its efficacy and safety when compared with dual drug regimens. Results have been posted…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Facilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions [NA]
Massachusetts General Hospital is testing facilitated transitions from postpartum care to primary care coordination for people with chronic …
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating whether adding valsartan and celecoxib to metformin provides superior outcomes versus metformin alo…
-
FDA approval · 2025-06-02FDA Approved: HYDRALAZINE HYDROCHLORIDE — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approves the Original Application for Hydralazine hydrochloride as a generic product by Meitheal Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Interdisciplinary Collaborative Care Model Combined With Family Empowerment in Comorbid Hypertension and Diabetes [NA]
This completed clinical trial evaluates an interdisciplinary collaborative care model, enhanced with family empowerment, for improving blood…
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: A Study to Investigate the Effect of Urine Acid-base Disequilibrium on the Pharmacokinetics of Captopril [Phase 1]
A Phase 1 study completed to investigate how urine acid-base imbalance affects the pharmacokinetics of captopril in hypertension.
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Building a Multidisciplinary Research Program to Address Hypertension Disparities: Exploring the Neurocognitive Mechanisms of a Self-Management Intervention for African American Women [NA]
This clinical trial update describes a multidisciplinary program addressing hypertension disparities and explores the neurocognitive mechani…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Immediate Fracture Risk After Antihypertensive Drug Initiation
Clinical trial investigating whether starting antihypertensive therapy influences immediate fracture risk.
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Goal Setting and Mobile-based Self-management Tool to Improve Diet Quality of People With High Blood Pressure [NA]
This clinical trial update describes an ongoing study evaluating a goal-setting and mobile-based self-management tool to improve diet qualit…
-
CLINICAL_TRIALS trial_result · 2025-05-25Clinical Trial Update: LCZ696 in Advanced LV Hypertrophy and HFpEF [Phase 2]
A Phase 2 trial of LCZ696 (sacubitril/valsartan) in advanced left ventricular hypertrophy and heart failure with preserved ejection fraction…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Implementation of the COmmunity HEalth System InnovatiON Project in Low- and Middle- Income Countries [NA]
This clinical trial update describes the implementation of the Community Health System Innovation Project across low- and middle-income coun…
-
CLINICAL_TRIALS trial_result · 2025-05-25Clinical Trial Update: Bioequivalence Study of Azilsartan Medoxomil 80 mg Tablets (Gedeon Richter Plc., Hungary) and Edarbi® 80 mg Tablets (JSC Nizhpharm, Russia) [Phase 1]
A Phase 1 bioequivalence study comparing azilsartan medoxomil 80 mg tablets from Gedeon Richter with Edarbi 80 mg tablets for hypertension; …
-
FDA approval · 2025-05-23FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Apotex Corp.)
FDA approved a supplemental abbreviated new drug application (ANDA) for Apotex Corp. to market a generic fixed-dose combination of amlodipin…
-
EMA approval · 2025-05-23EMA Authorised: Ifirmasta (previously Irbesartan Krka) (irbesartan hydrochloride) — Krka, d.d., Novo mesto
EMA has authorised Ifirmasta (irbesartan hydrochloride) by Krka for the treatment of hypertension. It is an authorised generic version of ir…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Primary Prevention Long-term Registry Study in OSA and Hypertension. Survival Analysis 2010-2022
A completed clinical trial registry update for a primary prevention long-term registry study evaluating outcomes in patients with hypertensi…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Community Engagement Alliance Against Disparities [NA]
Johns Hopkins University's Community Engagement Alliance Against Disparities trial is currently recruiting participants for diabetes, pre-di…
-
FDA approval · 2025-05-22FDA Approved: AMLODIPINE AND ATORVASTATIN — Original Application (Alembic Pharmaceuticals Inc.)
FDA approves Alembic Pharmaceuticals' fixed-dose combination of amlodipine and atorvastatin under an original ANDA application.
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary Hypercholesterolemia [Phase 3]
This Phase 3 clinical trial is evaluating the efficacy and safety of co-administered HODO-2224-1 and HODO-2224-2 in adults with essential hy…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Vibrometer Based Pulse Wave Analysis for Arterial Stiffness and Ischemic Heart Disease Risk Assessment
A vibrometer-based pulse wave analysis tool is being studied to assess arterial stiffness and ischemic heart disease risk, with the trial cu…